BioSpace News Archive

Biotech Bay

Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences - March 5, 2024

Mirum Pharmaceuticals, Inc. today announced that it will participate in the following upcoming investor conferences.

March 5, 2024
·
2 min read
Lone Star Bio

Lantern To Participate in H.C Wainwright & Co.’s (HCW) 1st Annual Artificial Intelligence Based Drug Discovery & Development Virtual Conference

Lantern Pharma will present virtually on Thursday, March 7th at 2 pm Eastern.

March 5, 2024
·
6 min read
Drug Development

Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule

Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that its Phase 2 SOLSTICE clinical trial evaluating the safety, tolerability and efficacy of tobevibart and elebsiran for the treatment of people living with chronic hepatitis delta (CHD) virus has completed enrollment.

March 5, 2024
·
6 min read
Biotech Bay

Twist Bioscience Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing

Twist Bioscience Corporation today announced European Union (EU) in vitro diagnostic regulations (IVDR) compliant Twist Precision Dx next-generation sequencing (NGS) Products.

March 5, 2024
·
7 min read
Genetown

Newly Published Results Reveal a Significant Proportion of Early-Stage HR+ Breast Cancer Survivors May Be Over- or Undertreated Without Breast Cancer Index Genomic Testing

Hologic, Inc. and its subsidiary, Biotheranostics, Inc., announced newly published study results revealing that use of the Breast Cancer Index® test led to physicians changing their long-term anti-estrogen treatment recommendations for 40% of patients with early-stage hormone receptor-positive breast cancer.

March 5, 2024
·
9 min read
Drug Development

FSD Pharma Presents Positive Results on First-In-Human Phase-1 study of Lucid-21-302 (Lucid-MS) at Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) 2024 Forum

FSD Pharma Inc. today announced its participation in Americas Committee for Treatment and Research in Multiple Sclerosis 2024 Forum held during Feb. 29 - Mar 2, 2024, in West Palm Beach, Florida.

March 5, 2024
·
7 min read
Business

Aptevo Therapeutics Reports 2023 Financial Results and Provides a Business Update

Aptevo Therapeutics Inc. today reported financial results for the year ended December 31, 2023 and provided a business update.

March 5, 2024
·
13 min read
Business

Allogene Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update

Allogene Therapeutics, Inc. today announced that it will report fourth quarter and full year 2023 financial results and provide a business update on March 14, 2024, after the close of the market.

March 5, 2024
·
2 min read
BioCapital

Michael F. Roizen, MD to Increase Activities with Telomir Pharmaceuticals as Special Advisor on Age Reversal

Telomir Pharmaceuticals, Inc. announced that Michael F. Roizen, MD, a leader in age-related medicine and an existing advisor to the Company, will be increasing his role in the coming months as a Special Advisor on Age Reversal.

March 5, 2024
·
5 min read
Biotech Beach

Regen BioPharma, Inc. to Present at the Emerging Growth Conference on March 7, 2024

Regen BioPharma, Inc. will be presenting at the Emerging Growth Conference on March 7, 2024.

March 5, 2024
·
3 min read